Francisco Javier Carrasco-Sanchez
Overview
Explore the profile of Francisco Javier Carrasco-Sanchez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
249
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pina Belmonte A, Madrazo M, Piles L, Rubio-Rivas M, de Jorge Huerta L, Gomez Antunez M, et al.
Can J Respir Ther
. 2024 Jun;
60:86-94.
PMID: 38855380
Background: Patients with chronic lung disease (CLD), such as asthma or chronic obstructive pulmonary disease, were expected to have an increased risk of clinical manifestations and severity of COVID-19. However,...
2.
Carretero-Gomez J, Carrasco-Sanchez F, Fernandez-Rodriguez J, Casado-Escribano P, Miramontes-Gonzalez J, Segui-Ripoll J, et al.
Rev Clin Esp (Barc)
. 2022 Dec;
223(3):134-143.
PMID: 36549643
Aim: This work aims to assess the effect of weekly subcutaneous semaglutide on biomarkers of metabolic-associated fatty liver disease (MAFLD), namely the hepatic steatosis index (HSI) and the fibrosis-4 (FIB-4)...
3.
Carretero-Gomez J, Perez-Martinez P, Segui-Ripoll J, Carrasco-Sanchez F, Lois Martinez N, Fernandez Perez E, et al.
J Clin Med
. 2022 Aug;
11(16).
PMID: 36012889
Background: Describe the profile of patients with obesity in internal medicine to determine the role of adiposity and related inflammation on the metabolic risk profile and, identify various “high-risk obesity”...
4.
Mendez-Bailon M, Iguaran-Bermudez R, Formiga-Perez F, Arevalo Lorido J, Suarez-Pedreira I, Morales-Rull J, et al.
J Clin Med
. 2022 Apr;
11(7).
PMID: 35407495
Background: Heart failure (HF) is a syndrome with high prevalence, mainly affecting elderly patients, where the presence of associated comorbidities is of great importance. Methods: An observational study from a...
5.
Carrasco-Sanchez F, Carretero-Anibarro E, Gargallo M, Gomez-Huelgas R, Merino-Torres J, Orozco-Beltran D, et al.
Endocrinol Diabetes Nutr (Engl Ed)
. 2022 Mar;
69(3):209-218.
PMID: 35353681
Background: This consensus aims to clarify the role of Dipeptidyl Peptidase-4 inhibitors (iDPP-4) in managing patients with diabetes during the COVID-19 pandemic. Materials And Methods: A PubMed bibliographic search was...
6.
Carrasco-Sanchez F, Carretero-Anibarro E, Gargallo M, Gomez-Huelgas R, Merino-Torres J, Orozco-Beltran D, et al.
Endocrinol Diabetes Nutr
. 2021 Nov;
69(3):209-218.
PMID: 34778721
Background: This consensus aims to clarify the role of Dipeptidyl Peptidase-4 inhibitors (iDPP-4) in managing patients with diabetes during the COVID-19 pandemic. Materials And Methods: A PubMed bibliographic search was...
7.
Gracia-Ramos A, Carretero-Gomez J, Mendez C, Carrasco-Sanchez F
Curr Med Res Opin
. 2021 Oct;
38(1):43-53.
PMID: 34694181
Hyperglycemia in hospitalized patients, either with or without diabetes, is a common, serious, and costly healthcare problem. Evidence accumulated over 20 years has associated hyperglycemia with a significant increase in...
8.
Carretero Gomez J, Ena J, Segui Ripoll J, Carrasco-Sanchez F, Gomez Huelgas R, Casas Rojo J, et al.
Curr Med Res Opin
. 2021 Aug;
37(11):1867-1873.
PMID: 34357836
Aim: To assess the efficacy of sodium-glucose cotransporter-2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptors agonist (GLP-1RA) therapy on liver steatosis measured by fatty liver index (FLI) and hepatic steatosis index...
9.
Loureiro-Amigo J, Suarez-Carantona C, Oriol I, Sanchez-Diaz C, Coloma-Conde A, Manzano-Espinosa L, et al.
Arch Bronconeumol
. 2021 Jun;
58(3):277-280.
PMID: 34121796
No abstract available.
10.
Ramos-Rincon J, Perez-Belmonte L, Carrasco-Sanchez F, Jansen-Chaparro S, De-Sousa-Baena M, Bueno-Fonseca J, et al.
J Gerontol A Biol Sci Med Sci
. 2021 May;
76(8):e102-e109.
PMID: 33945610
Background: The effects of cardiometabolic drugs on the prognosis of diabetic patients with COVID-19, especially very old patients, are not well known. This work was aimed to analyze the association...